SCHEMBL19081186

SCHEMBL19081186

CC1(C)c2cc3ccccc3cc2-c2c1c(-c1ccc(-c3c4ccccc4c(-c4ccccc4)c4ccccc34)cc1)cc1c2sc2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
ALOX5 P09917 1/20 0.34
MAPT P10636 2/20 0.34
ALK Q9UM73 1/20 0.33
F9 P00740 1/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
MAPK1 P28482 1/20 0.32
RAB9A P51151 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081098 0.88 ALOX5 (0.34) ALOX5MAPTALKATML3MBTL1
SCHEMBL17932247 0.88 ALOX5 (0.39) TNKSTNKS2ALOX5MAPTALK
SCHEMBL17944765 0.85 ALOX5 (0.36) ALOX5MAPTALKNPC1ALDH1A1
SCHEMBL17945364 0.82 ALOX5 (0.40) TNKSTNKS2ALOX5MAPTF9
SCHEMBL19081160 0.82 ALK (0.32) ALOX5MAPTALKF9ESR1
SCHEMBL17851816 0.80 ALOX5 (0.42) ALOX5MAPTALKF9
SCHEMBL19081202 0.80 ALOX5 (0.35) ALOX5MAPTF9ATML3MBTL1
SCHEMBL17944363 0.80 ALOX5 (0.36) ALOX5MAPTATML3MBTL1
SCHEMBL17851840 0.80 ALOX5 (0.41) ALOX5MAPT
SCHEMBL19109599 0.79 ALOX5 (0.39) TNKSTNKS2ALOX5MAPTF9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TNKS 2635/4885TNKS2 2644/4885ALOX5 1939/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TNKS 2635/4885TNKS2 2644/4885ALOX5 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.